Prolonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis

American Journal of Gastroenterology

Volumn 99, Issue 2, 2004, Pages 264-268

  Combes, Burton ^a   Luketic, Velimir A ^b   Peters, Marion G ^b   Zetterman, Rowen K ^b   Garcia Tsao, Guadalupe ^b   Munoz, Santiago J ^b   Lin, Danyu ^b   Flye, Nancy ^b   Carithers Jr , Robert L ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT REFERRAL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; SURVIVAL TIME;

CHOLAGOGUES AND CHOLERETICS; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; URSODEOXYCHOLIC ACID;

EID: 1442326020     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04047.x     Document Type: Article

References (12)

1. Poupon RE, Poupon R, Balkau B for the UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. New Engl J Med 1994;330:1342-7.
2. Poupon RE, Balkau B, Eschwege E, et al. The UDCA-PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. New Engl J Med 1991;324:1548-51.
3. Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-90.
4. Heathcote EJ, Cauch-Dudek K, Walker V, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994;19:1149-56.
5. Poupon RE, Lindor KD, Cauch-Dudek K, et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-90.
6. Combes B, Carithers RL Jr., Maddrey WB, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995;22:759-66.
7. Carithers RL Jr., Luketic VA, Peters M, et al. Extended follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Gastroenterology 1996;110:A1163.
8. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchow's Arch A 1978;379:103-12.
9. Kilmurry MR, Heathcote EJ, Cauch-Dudek K, et al. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology 1996;23:1148-53.
10. Eriksson LS, Olsson R, Glauman H, et al. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scand J Gastroenterol 1997;32:179-86.
11. Lindor KD, Therneau TM, Jorgensen RA, et al. Effect of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996;110:1515-8.
12. Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis. Lancet 1999;354:1053-60.